Slater and Gordon investigating class action into IVF add-on therapies

Firm says there are “serious question marks over the efficacy of the techniques”

Slater and Gordon investigating class action into IVF add-on therapies

Slater and Gordon has announced that it is investigating the possibility of commencing a class action suit on behalf of women who have been sold ineffective add-on therapies while undergoing in vitro fertilisation (IVF) treatment.

Margaret Kent, practice group leader at Slater and Gordon, said the add-ons were “expensive and there were serious question marks over the efficacy of the techniques.”

“We have been investigating this practice for many months and have spoken to leading researchers and practitioners in the area,” said Kent. “Particularly in the case of pre-implantation genetic testing for aneuploidy (PGT-A), there is significant evidence to suggest that the test is not an effective determination of an embryo’s chance of culminating in a live birth.”

Kent added that pre-implantation genetic testing “can cost up to $895 per embryo and if a woman is having multiple rounds of IVF that can quickly add up to a significant additional cost.”

“If you are trying to get pregnant of course you are going to want to maximise your chance of success, but there is insufficient credible evidence to show PGT-A does in fact increase the probability of having a baby,” said Kent. “In fact, there is evidence that PGT-A may even reduce the overall chance of a live birth in a cycle. Frankly, we think people who are already incredibly vulnerable are getting ripped off.”

According to Kent, the firm estimates that more than 8,000 women have been sold pre-implant genetic testing – a test that supposedly determines the likelihood of the embryo proceeding to a live birth – in Australia and New Zealand in the past 12 months.

Kent said that, while the firm was particularly concerned about the efficacy of pre-implantation genetic testing, they are also investigating the selling of add-on treatments more broadly.

“Going through IVF is incredibly stressful – physically, emotionally and financially – and it is incredibly concerning that women are being encouraged to spend more for additional treatments or procedures that have no proven benefit,” said Kent.

Related stories

Free newsletter

Subscribe to our FREE newsletter service and we’ll keep you up-to-date with the latest breaking news, cutting edge opinion, and expert analysis affecting both your business and the industry as whole.

Please enter your email address below and click on Sign Up for daily newsletters from Australasian Lawyer.

Recent articles & video

"Stay in Sydney" – NSW hit by "very serious" outbreak

KWM bolsters partnership with 10 promotions

Baker McKenzie advises HSBC on billion-dollar sustainability-linked loan

UK Bar Council voices support for trans-inclusivity in the legal profession

Australasian Lawyer opens entries for its Fast Firms 2021 report

Money no longer the biggest drawing card for New York’s legal talent, study finds

Most Read Articles

New CEO steps up at MinterEllison

Sydney trademark law star named NRF’s new global IP head

Australasian Law Awards 2021 crowns the winners of the industry and firm categories

‘Being a commercial lawyer is about more than just the law,’ Lander & Rogers partner says